Kevin Raymond Merrill Smith Inogen Inc (INGN) insider trading activity

Kevin Raymond Merrill Smith is CEO and President of Inogen Inc. Currently has a direct ownership of 86,291 shares of INGN, which is worth approximately $595,407. The most recent transaction as insider was on Dec 01, 2025, when has been sold 13,817 shares (Common Stock) at a price of $6.95 per share, resulting in proceeds of $96,028. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.3K

20.23% 3M change

492.9% 12M change

Total Value Held $595,407

Kevin Raymond Merrill Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2025	SELL Payment of exercise price or tax liability	$96,028 $6.95 p/Share	13,817 Reduced 13.8%	86,291 Common Stock
Dec 01 2025	BUY Exercise of conversion of derivative security	-	28,334 Added 22.06%	100,108 Common Stock
Sep 01 2025	BUY Grant, award, or other acquisition	$11,985 $7.99 p/Share	1,500 Added 2.05%	71,774 Common Stock
Mar 03 2025	BUY Open market or private purchase	$100,229 $8.56 p/Share	11,709 Added 14.28%	70,274 Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$331,509 $8.33 p/Share	39,797 Reduced 40.46%	58,565 Common Stock
Mar 01 2025	BUY Exercise of conversion of derivative security	-	28,333 Added 38.96%	44,387 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	$231,330 $4.17 p/Share	55,475 Added 39.59%	84,662 Common Stock

Dec 01 2024	SELL Payment of exercise price or tax liability	$133,794 $9.71 p/Share	13,779 Reduced 48.63%	14,554 Common Stock
Dec 01 2024	BUY Exercise of conversion of derivative security	-	28,333 Added 50.0%	28,333 Common Stock

Also insider at

ONCS

ONCOSEC MEDICAL Inc Healthcare

Director

KRM